E11
Conditions
Interventions
Group 1: Placebo: Placebo is given out in 20ml bottles. Patients are asked to take 10ml ( one table spoon) of the fluid twice a day before breakfast and dinner respectively over a period of 12 weeks.
Sponsors
Else Kröner-Fresenius-Zentrum für Ernährungsmedizin der TU München Lehrtsuhl für Ernährungsmedizin
Eligibility
Sex/Gender
All
Age
25 Years to 73 Years
Inclusion criteria
Inclusion criteria: Diabetes mellitusType 2 at least for 1 year,HbA1c > 6,5 und < 10,0%, stable metabolic control for 3 months prior to study entry, BMI 25-40 kg/m2, stable body weight (+/- 2kg in the last 3 months), written informed consent
Exclusion criteria
Exclusion criteria: insulin treatment; known allergies to nuts, citrus fruits, dates, soja, coconut, sellerie, oranges; uncontrolled arterial hypertension (= 160/95 mmHg); instable coronary heart disease; psychiatric diseases; serious illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The HbA1c is measured in the blood at the beginning and the end of the treatment period of 12 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fructosamine, hsCRP, HMW-adiponectin, uric acid, chromium in plasma,and zinc in plasma are measured in the blood at the beginning and the end of the treatment period of 12 weeks. Total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides, fasting blood glucose, insulin, GOT, GPT, gGT are measured in the blood at week 0, 4, and 12. Bodyweight and blood pressure are measured at week 0, 4, and 12. | — |
Countries
Germany
Contacts
Public ContactThomas Skurk
Else Kröner-Fresenius-Zentrum für Ernährungsmedizin der TU München Lehrstuhl für Ernährungsmedizin
Outcome results
None listed